BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12665686)

  • 21. Expression of somatostatin receptors in human pancreatic tumor.
    Tang C; Biemond I; Verspaget HW; Offerhaus GJ; Lamers CB
    Pancreas; 1998 Jul; 17(1):80-4. PubMed ID: 9667524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas.
    Scarpa A; Orlandini S; Moore PS; Lemoine NR; Beghelli S; Baron A; Falconi M; Zamboni G
    Virchows Arch; 2002 Feb; 440(2):155-159. PubMed ID: 11964045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas.
    Fjällskog ML; Hessman O; Eriksson B; Janson ET
    Acta Oncol; 2007; 46(6):741-6. PubMed ID: 17653895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.
    Waser B; Tamma ML; Cescato R; Maecke HR; Reubi JC
    J Nucl Med; 2009 Jun; 50(6):936-41. PubMed ID: 19443580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer cells expressing hypoxia-inducible factor-1α tend to be adjacent to intratumoral blood vessels.
    Cheng BQ; Segersvärd R; Permert J; Wang F
    Eur Surg Res; 2010; 45(3-4):134-7. PubMed ID: 20924188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors.
    Rubbia-Brandt L; Terris B; Giostra E; Dousset B; Morel P; Pepper MS
    Clin Cancer Res; 2004 Oct; 10(20):6919-28. PubMed ID: 15501970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
    Ueberberg B; Tourne H; Redmann A; Walz MK; Schmid KW; Mann K; Petersenn S
    Horm Metab Res; 2005 Dec; 37(12):722-8. PubMed ID: 16372224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
    Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
    J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.
    Wester HJ; Schottelius M; Scheidhauer K; Meisetschläger G; Herz M; Rau FC; Reubi JC; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):117-22. PubMed ID: 12483418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.
    Binderup T; Knigge U; Mellon Mogensen A; Palnaes Hansen C; Kjaer A
    Neuroendocrinology; 2008; 87(4):223-32. PubMed ID: 18196892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
    Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ
    Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissues.
    Unger N; Ueberberg B; Schulz S; Saeger W; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):482-9. PubMed ID: 22976314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
    Sampedro-Núñez M; Luque RM; Ramos-Levi AM; Gahete MD; Serrano-Somavilla A; Villa-Osaba A; Adrados M; Ibáñez-Costa A; Martín-Pérez E; Culler MD; Marazuela M; Castaño JP
    Oncotarget; 2016 Feb; 7(6):6593-608. PubMed ID: 26673010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.
    Lupp A; Nagel F; Doll C; Röcken C; Evert M; Mawrin C; Saeger W; Schulz S
    Neuroendocrinology; 2012; 96(4):301-10. PubMed ID: 22414742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of somatostatin receptors in ependymoma: implications for diagnosis.
    Guyotat J; Champier J; Jouvet A; Signorelli F; Houzard C; Bret P; Saint Pierre G; Fevre Montange M
    Int J Cancer; 2001 May; 95(3):144-51. PubMed ID: 11307146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptor gene expression in neuroblastoma.
    Albers AR; O'Dorisio MS; Balster DA; Caprara M; Gosh P; Chen F; Hoeger C; Rivier J; Wenger GD; O'Dorisio TM; Qualman SJ
    Regul Pept; 2000 Mar; 88(1-3):61-73. PubMed ID: 10706954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
    Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
    Kumar U
    J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
    Szepeshazi K; Schally AV; Halmos G; Sun B; Hebert F; Csernus B; Nagy A
    Clin Cancer Res; 2001 Sep; 7(9):2854-61. PubMed ID: 11555603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.